← Book Three · The American Healthcare Investigation
Beyond Reform
Designing the Future of American Healthcare Financing
If America were designing its healthcare financing system today, on a blank sheet of paper, what would it build? Beyond Reform sets out what must never be lost from American medicine, establishes seven principles any good financing system must honor regardless of party or model, studies six other nations not to copy them but to learn what their differing designs prove, and confronts the hardest objections — cost, taxes, innovation, jobs, clinical independence — honestly and in turn. Its conclusion is carefully limited: the evidence supports replacing the financing architecture rather than continuing to patch it, but the choice of what replaces it belongs to the public, not the author.
The Investigation
What this book is about
Imagine a blank sheet of paper. No insurance companies. No government programs. No employer coverage, no billing codes, no prior-authorization queues — nothing yet built, nothing yet broken. Only the sheet, and a single responsibility: design a financing system capable of supporting the best possible health care for more than three hundred million people. Where would you begin?
That is the question Robert W. Coleman poses at the opening of Beyond Reform, the third and final volume of The American Healthcare Investigation. It is a strange question to ask after two books of hard diagnosis, and that is precisely the point. Book One, Before the Counter, began with something small and personal — the price of a prescription that seemed to come from nowhere. Book Two, Behind the System, traced the machinery further still, showing how a financing system built to support American medicine had, over decades, grown to overtake the care it was meant to serve. By the end of that investigation, one conclusion was difficult to avoid: the drug prices, the surprise bills, the denied authorizations, the vanishing rural wards were not separate failures. They were symptoms of a single underlying design.
That finding changes the question completely. It stops being "how do we fix this next problem?" and becomes something more fundamental: if we were building an American health-care financing system today, knowing everything this investigation has revealed, what would we build? That is not a political question, Coleman insists — it is a design question. Beyond Reform is his attempt to ask it honestly, and to answer as much of it as evidence — rather than ideology — can responsibly answer.
The Design Challenge
The book opens by noticing something about the way Americans normally argue about health care: the debate almost always starts in the middle. It begins with a program to expand, a mandate to add, a price to cap — with policy — and works backward, if it works backward at all, toward some vague sense of purpose. Good design runs the opposite direction. It starts with purpose, then works out principles, then a model, and only at the very end, specific policies.
What is striking, once the question is asked this way, is how much agreement appears. Should a financing system provide reliable access to care? Should it encourage medical innovation? Should it use limited resources responsibly? Almost no one disagrees with any of that. People argue fiercely about solutions — single-payer versus regulated competition versus some blend — but they agree remarkably about goals.
None of this makes the design easy, because the goals genuinely pull against each other. A financing system has to balance access, quality, innovation, sustainability, and public trust, knowing it cannot maximize all five at once. The honest task, Coleman argues, is not to eliminate trade-offs but to make them deliberately and openly, in service of a clearly stated purpose.
What Must Never Be Lost
A book titled Beyond Reform could easily sound like a demolition order, and Coleman is careful, in his second chapter, to make sure it isn't one. Before deciding what to change, a careful designer asks the opposite question first: what, in American health care, must never be lost?
The target of this entire investigation has always been the financing architecture — the incentives, the fragmentation, the administrative machinery. It has never been American medicine or the people who practice it. There is the research engine: a landmark study found that NIH-funded research was associated with every one of the 210 new drugs the FDA approved between 2010 and 2016, representing more than one hundred billion dollars in cumulative grant funding. There is the education pipeline — the teaching hospitals and schools that renew the workforce. There is the country's genuine diversity of care settings — academic medical centers, community hospitals, rural clinics, veterans' hospitals, independent practices.
A proposed financing system earns the word "replace," in Coleman's framing, only if it protects these strengths better than today's arrangement does. Uniform financing does not require uniform medicine — a single, coherent set of rules for how money moves can sit beneath a rich diversity of ways to actually deliver care.
Principles Before Models
Having established what to protect, Coleman turns to how to build. Across the investigation, seven principles recur wherever financing serves people well. Four will be familiar to readers of Book Two: simplicity, alignment, transparency, and accountability. To these, Coleman adds three principles a forward-looking design especially requires: sustainability, flexibility, and trust — the principle he calls the one most tempting to treat as a happy byproduct, and the one whose absence quietly defeats everything else.
The crucial point about all seven is what none of them does: not one belongs to a political party, a financing model, or a particular size of government. A single-payer system can pursue simplicity and sustainability, or fail at them. A system of regulated private insurers can be transparent and trustworthy, or opaque and brittle. The principles set a bar that many different designs can clear or miss.
Learning from the World, Without Copying It
Principles remain abstractions until someone builds with them. Coleman walks through six nations, each illustrating one distinct lesson. Canada demonstrates administrative simplicity. Germany shows that regulated competition can coexist with universal coverage — roughly a hundred nonprofit "sickness funds" compete for members inside one national rulebook. Taiwan proves how far information technology can carry a system: its single-payer program runs on a smart card every resident carries, keeps administration to roughly one or two percent of spending, and pays providers within weeks. Australia shows coexistence between a public program and private insurance sold on top. France offers continuity through complementary coverage layered over a strong statutory base. And Japan holds costs down through discipline rather than denial — a single national fee schedule, revised every two years.
These systems do not share a model. Canada and Taiwan are single-payer; Germany runs regulated competition among many nonprofit insurers; Australia blends public and private; France layers complementary coverage over social insurance; Japan uses many insurers bound by one national price list. And yet they converge on the same handful of strengths. If nations running opposite models all reach similar strengths, those strengths cannot belong to any one model — they belong to the design principles the models happen to share. He is careful to correct a common claim along the way: it is not true that "every other wealthy country uses single-payer." Germany, the Netherlands, and Switzerland all reach universal coverage through regulated private insurance, not a single public payer.
Designing an American Solution
With the strengths to preserve, the principles to honor, and the lessons the world can teach all on the table, Coleman turns to the concrete question: what would an American design actually look like? His answer is deliberately unusual for a book with this title — he describes characteristics without naming a model, on the grounds that naming the model is not a designer's decision to make. It belongs to a democracy.
The organizing characteristic is that financing should support medicine, not control it. Administration should be simplified until it serves care rather than competing with it. Incentives should be aligned so that organizations succeed when patients get healthier. Coleman adds a distinctively American caution: the country is too large, too varied, and too innovative for a single rigid template imposed uniformly from the top. The answer is to separate principles, which should be common and national, from implementation, which can and should adapt locally.
“The architecture is the evidence's conclusion. The model is democracy's verdict.”— Beyond Reform
The Difficult Questions
A description of characteristics, however careful, is not yet a plan a country can act on, and Coleman's sixth chapter takes on the hard, practical objections directly. On cost, he reframes the usual question: the more honest question is whether the country can afford to keep financing care exactly as it does now, given that costs have grown for decades faster than inflation and faster than wages. On taxes, Americans already spend roughly fourteen to fifteen thousand dollars per person each year on health care, routed through premiums, deductibles, copayments, and employer contributions — the honest comparison is never "new taxes versus nothing," it is the total cost of financing care one way against the total cost of financing it another.
On clinical independence, he offers the book's most concrete test: picture the exam room. A design passes when there are two parties in it — the clinician and the patient — and the financing waits outside the door, ready to pay for whatever they decide together. It fails the moment a third party who has never met the patient acquires a veto over what happens inside. On employer coverage and jobs, he refuses easy comfort in either direction, acknowledging that millions of Americans would be affected by large-scale change, and that any responsible redesign has to treat that human cost as a design problem to be solved with real seriousness.
Beyond Reform
The book's final chapter states the trilogy's conclusion plainly, and states with equal plainness what that conclusion does not include. For decades, America has worked to improve its health-care system, and much of that work genuinely succeeded — coverage expanded, quality improved, patient safety advanced, scientific discovery accelerated. But for all of it, the reforms never changed the architecture beneath the system — the fragmented financing, the misaligned incentives, the administrative machinery.
He returns to the renovation image that has run through the trilogy: you can repair the roof, replace the windows, modernize the wiring, upgrade the plumbing, and each improvement is genuine and worth doing. But if the foundation itself no longer supports the building, there comes a point where no further renovation will fix what the foundation is causing.
And then comes the sentence Coleman calls the most careful in the book. The evidence, he argues, supports a conclusion: that the productive path forward is to replace the financing architecture rather than keep reforming its parts. But the evidence does not deliver a verdict on which model should carry that new architecture. That choice belongs to a democratic public, weighing values that evidence can inform but cannot settle. The architecture is the evidence's conclusion. The model is democracy's verdict.
Closing the Trilogy
Beyond Reform ends the way the whole investigation began: at ground level, with a reminder of what health care actually is in a human life. Health care is present at birth, Coleman writes in the epilogue. It stands beside us in illness. It comforts us in moments of uncertainty and remains with us as we grow older.
The trilogy closes not with a verdict but with an invitation. Having followed the evidence from a pharmacy counter, through the financing system's architecture, to the principles that should guide its future, Coleman offers a conclusion about that architecture and hands the harder, larger decision — which model, which blueprint, which balance of public and private — to the public it will ultimately serve.
The most liberating finding of the whole investigation, Coleman suggests, is also its simplest: health-care financing is not a fact of nature or an unavoidable inheritance. It is something human beings built, deliberately, one decision at a time — which means it is also something human beings can rebuild, deliberately, one decision at a time. The house, in his recurring image, is never torn down. American medicine — its clinicians, its science, its extraordinary capacity for discovery — remains standing throughout, protected rather than threatened by the argument. The investigation, Coleman writes in its closing lines, is complete. The conversation, at last, is only beginning.
Not the same book as the standalone Replace, Don't Reform — this trilogy volume was originally drafted under that title before being renamed. How the two relate. Looking for a concrete policy blueprint rather than design principles? See the case for single-payer.